Rules allow drug developers to list on the bourse before they sell any products to patients
Related Posts
Cross-border China shares closer to parity
Alibaba looks to raise billions in Hong Kong listing
China biotechs spend billions on new drug candidates
Chinese game streamer DouYu to raise up to $944m in US IPO- Wu Jinzi: The challenges of taking on big pharma
China Tower seeks to raise up to $8.7bn in Hong Kong listing
China's Maoyan Hong Kong IPO to sell at bottom of range- Hong Kong exchange hopes Xiaomi leads army of blockbuster IPOs
HK debate over listing rules
Tencent Cloud Opens Outside Mainland China While Foreign Tech Still Blocked Inside Country
